Alendronate treatment promotes bone formation with a less anisotropic microstructure during intramembranous ossification in rats

[1]  Claus Christiansen,et al.  Are Nonresorbing Osteoclasts Sources of Bone Anabolic Activity? , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  D. Burr,et al.  Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia. , 2006, Bone.

[3]  C. Turner,et al.  Dissociation of mineral and collagen orientations may differentially adapt compact bone for regional loading environments: results from acoustic velocity measurements in deer calcanei. , 2006, Bone.

[4]  Y. Tabata,et al.  Role of Osteoclast in Preferential Alignment of Biological Apatite (BAp) in Long Bones , 2006 .

[5]  I. Martin,et al.  Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells. , 2005, Biomaterials.

[6]  N. Udagawa,et al.  Reduced osteoblastic population and defective mineralization in osteopetrotic (op/op) mice. , 2005, Micron.

[7]  T. Diab,et al.  Effects of damage morphology on cortical bone fragility. , 2005, Bone.

[8]  R O Ritchie,et al.  Fracture in human cortical bone: local fracture criteria and toughening mechanisms. , 2005, Journal of biomechanics.

[9]  M. Morris,et al.  Bone Chemical Structure Response to Mechanical Stress Studied by High Pressure Raman Spectroscopy , 2005, Calcified Tissue International.

[10]  S. Manolagas,et al.  Bisphosphonates and Estrogens Inhibit Osteocyte Apoptosis via Distinct Molecular Mechanisms Downstream of Extracellular Signal-regulated Kinase Activation* , 2005, Journal of Biological Chemistry.

[11]  J G Clement,et al.  Relationships among microstructural properties of bone at the human midshaft femur , 2005, Journal of anatomy.

[12]  C. Hernandez,et al.  Osteocyte density in woven bone. , 2004, Bone.

[13]  M. Akhter,et al.  Osteoclast Deficiency Results in Disorganized Matrix, Reduced Mineralization, and Abnormal Osteoblast Behavior in Developing Bone , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  H. Rubash,et al.  Osteoblast proliferation and maturation by bisphosphonates. , 2004, Biomaterials.

[15]  K. Hunt,et al.  Does the degree of laminarity correlate with site‐specific differences in collagen fibre orientation in primary bone? An evaluation in the turkey ulna diaphysis , 2004, Journal of anatomy.

[16]  K. Hunt,et al.  Relationships of loading history and structural and material characteristics of bone: Development of the mule deer calcaneus , 2004, Journal of morphology.

[17]  E. Margerie,et al.  Assessing a relationship between bone microstructure and growth rate: a fluorescent labelling study in the king penguin chick (Aptenodytes patagonicus) , 2004, Journal of Experimental Biology.

[18]  M. Balooch,et al.  Both hPTH(1–34) and bFGF Increase Trabecular Bone Mass in Osteopenic Rats but They Have Different Effects on Trabecular Bone Architecture , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  K. Takaoka,et al.  Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption. , 2003, Endocrinology.

[20]  F. Glorieux,et al.  Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. , 2003, The Journal of clinical endocrinology and metabolism.

[21]  T. Srivastava,et al.  The role of bisphosphonates in diseases of childhood , 2003, European Journal of Pediatrics.

[22]  D. Wenkert,et al.  Bisphosphonate-induced osteopetrosis. , 2003, The New England journal of medicine.

[23]  F. Glorieux,et al.  Bone Mass, Size, and Density in Children and Adolescents With Osteogenesis Imperfecta: Effect of Intravenous Pamidronate Therapy , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  A. Oberbauer,et al.  Alendronate affects long bone length and growth plate morphology in the oim mouse model for Osteogenesis Imperfecta. , 2003, Bone.

[25]  A. Boskey,et al.  Alendronate Treatment for Infants with Osteogenesis Imperfecta: Demonstration of Efficacy in a Mouse Model , 2002, Pediatric Research.

[26]  Y. Tabata,et al.  Unique alignment and texture of biological apatite crystallites in typical calcified tissues analyzed by microbeam X-ray diffractometer system. , 2002, Bone.

[27]  G. Marotti,et al.  Static and dynamic osteogenesis: two different types of bone formation , 2002, Anatomy and Embryology.

[28]  O. Fromigué,et al.  Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts , 2002, Journal of endocrinological investigation.

[29]  L. Root,et al.  A Controlled Study of the Effects of Alendronate in a Growing Mouse Model of Osteogenesis Imperfecta , 2001, Calcified Tissue International.

[30]  L. Plotkin,et al.  Bisphosphonate-Induced, Hemichannel-Mediated, Anti-Apoptosis Through the Src/ERK Pathway: A Gap Junction-Independent Action of Connexin43 , 2001, Cell communication & adhesion.

[31]  J. Ingle,et al.  Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. , 2000, Cancer research.

[32]  G W Marshall,et al.  Viscoelastic properties of demineralized human dentin measured in water with atomic force microscope (AFM)-based indentation. , 1998, Journal of biomedical materials research.

[33]  G. Passeri,et al.  Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo. , 1998, Bone.

[34]  D. Burr,et al.  Mineral anisotropy in mineralized tissues is similar among species and mineral growth occurs independently of collagen orientation in rats: Results from acoustic velocity measurements , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  J. Lin,et al.  Bisphosphonates: a review of their pharmacokinetic properties. , 1996, Bone.

[36]  J. Zanchetta,et al.  Effects of large doses of olpadronate (dimethyl-pamidronate) on mineral density, cross-sectional architecture, and mechanical properties of rat femurs. , 1995, Bone.

[37]  T. Wronski,et al.  Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats. , 1995, Bone.

[38]  D. Burr,et al.  Contribution of collagen and mineral to the elastic anisotropy of bone , 1994, Calcified Tissue International.

[39]  S. Doty,et al.  Alendronate increases skeletal mass of growing rats during unloading by inhibiting resorption of calcified cartilage , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  R. Goswami.  Primer on the metabolic bone diseases and disorders of mineral metabolism , 1994, The Indian Journal of Medical Research.

[41]  R. Martin,et al.  The effects of collagen fiber orientation, porosity, density, and mineralization on bovine cortical bone bending properties. , 1993, Journal of biomechanics.

[42]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987 .

[43]  W. Bonfield,et al.  Anisotropy of the Young's modulus of bone , 1977, Nature.

[44]  Walter P. Blount.  Fractures in Children , 1977 .

[45]  W. C. Hayes,et al.  Tensile testing of bone over a wide range of strain rates: effects of strain rate, microstructure and density , 1976, Medical and biological engineering.

[46]  O. Akkus,et al.  Local variations in the micromechanical properties of mouse femur: the involvement of collagen fiber orientation and mineralization. , 2007, Journal of biomechanics.

[47]  R. Rizzoli,et al.  Intrinsic bone tissue properties in adult rat vertebrae: modulation by dietary protein. , 2005, Bone.

[48]  P. Fratzl,et al.  Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse. , 2005, Bone.

[49]  Y. Tabata,et al.  Texture and Bone Reinforcement , 2005 .

[50]  L. Bachrach,et al.  Low-dose Intravenous Pamidronate Reduces Fractures in Childhood Osteoporosis , 2003, Journal of pediatric endocrinology & metabolism : JPEM.

[51]  D B Burr,et al.  Targeted and nontargeted remodeling. , 2002, Bone.

[52]  N. Sasaki,et al.  Orientation of bone mineral and its role in the anisotropic mechanical properties of bone--transverse anisotropy. , 1989, Journal of biomechanics.

[53]  S. Pollack,et al.  Haversian osteons: longitudinal variation of internal structure. , 1980, Journal of biomedical materials research.

[54]  W C Hayes,et al.  Fatigue life of compact bone--I. Effects of stress amplitude, temperature and density. , 1976, Journal of biomechanics.

[55]  P. Esposito,et al.  Osteogenesis Imperfecta. , 1928, Proceedings of the Royal Society of Medicine.